After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ABEO belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Abeona Therapeutics Inc is $281.01M. A total of 0.88 million shares were traded on the day, compared to an average of 896.69K shares.
In the most recent transaction, O’Malley Brendan M. sold 688 shares of ABEO for 5.43 per share on Sep 22 ’25. After the transaction, the SVP, Chief Legal Officer now owns 360,129 company shares. In a previous transaction on Sep 22 ’25, O’Malley Brendan M. bought 17,376 shares at 5.86 per share.
Among the insiders who sold shares, Crombez Eric disposed of 4,718 shares on Aug 14 ’25 at a per-share price of $6.93. This resulted in the Director holding 42,427 shares of ABEO after the transaction. In another insider transaction, Vazzano Joseph Walter sold 15,000 shares at $7.36 per share on Aug 15 ’25. Company shares held by the Chief Financial Officer now total 462,666.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ABEO has a high of $7.54 and a low of $3.93.
As of this writing, ABEO has an earnings estimate of -$0.34 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.32 per share and a lower estimate of -$0.38. The company reported an EPS of -$0.31 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ABEO’s latest balance sheet shows that the firm has $45.02M in Cash & Short Term Investments as of fiscal 2021. There were $9.38M in debt and $16.62M in liabilities at the time. Its Book Value Per Share was $3.19, while its Total Shareholder’s Equity was $42.37M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABEO is Buy with a score of 5.00.
